Related Experiment Video
Updated: Nov 2, 2025

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
The polarity protein PARD3 and cancer
Farzaneh Atashrazm1, Sarah Ellis2
1Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. f.atashrazm@gmail.com.
Partition defective 3 (PARD3) regulates cell polarity and tissue organization. This review explores PARD3
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Oncology
Background:
- Tissue disorganization is a hallmark of cancer.
- Polarity proteins, like Partition defective 3 (PARD3), control cell arrangement in epithelial tissues.
- PARD3 acts as a master regulator of the Par polarity complex and a scaffolding protein for signaling molecules.
Purpose of the Study:
- To review the dual role of PARD3 in tumorigenesis.
- To discuss PARD3's involvement in various solid cancers.
- To explore the mechanisms underlying PARD3's function in cancer.
Main Methods:
- Literature review of laboratory and clinical studies.
- Analysis of PARD3's scaffolding functions.
- Examination of PARD3's association with signaling pathways and cell division.
Main Results:
- PARD3 can act as either a tumor suppressor or promoter.
- Its function is dependent on physiological and cellular context.
- PARD3 interacts with deregulated signaling molecules in cancer.
Conclusions:
- PARD3 plays a complex, context-dependent role in cancer development.
- Understanding PARD3's mechanisms is crucial for cancer research.
- Further investigation into PARD3's interactions is warranted.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Cell Polarization by Rho Proteins
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cancer Cell Migration through Invadopodia

